Skip to main content

Advertisement

Figure 2 | Arthritis Research & Therapy

Figure 2

From: International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis

Figure 2

The total number of patients is 73, except for the columns with not determined (ND) samples. ACAs, anticentromere antibodies; ANAs, antinuclear antibodies; anti-CCPs, antibodies to cyclic citrullinated peptide; anti-SL (sicca/lupus), anti-Scl-70 (DNA topoisomerase I), anti-dsDNA, antibodies against double stranded DNA; aPLs, antiphospholipid antibodies; ND, data are not available, because of missing procedures necessary to define the particular parameter; PCNA, proliferating cell nuclear antigen; RF, rheumatoid factor; UDA-HSE and UDA-RTE, undefined antibodies as detected with CIE by using human spleen and rabbit thymus, respectively, as sources of antigens.

Back to article page